Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity
Main Authors: | Azmy, Iman AF, Balasubramanian, Saba P, Wilson, Anthony G, Stephenson, Timothy J, Cox, Angela, Brown, Nicola J, Reed, Malcolm WR |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2004
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC468647/ |
Similar Items
-
Tumor necrosis factor-alpha gene promoter -308 and -238 polymorphisms in patients with lung cancer as a second primary tumor
by: Flego, Veljko, et al.
Published: (2013) -
The Tumor Necrosis Factor-α-308 and -238 Polymorphisms and Risk of Hepatocellular Carcinoma for Asian Populations: A Meta-Analysis
by: Hu, Qing, et al.
Published: (2014) -
Tumour necrosis factor -308 and -238 promoter polymorphisms are
predictors of a null virological response in the treatment of Brazilian hepatitis C
patients
by: Grandi, Tarciana, et al.
Published: (2014) -
Tumor Necrosis Factor-Alpha Gene Promoter −308G/A and −238G/A Polymorphisms in Mexican Patients with Type 2 Diabetes Mellitus
by: Guzmán-Flores, Juan Manuel, et al.
Published: (2011) -
Endostatin gene variation and protein levels in breast cancer susceptibility and severity
by: Balasubramanian, Sabapathy P, et al.
Published: (2007)